These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8740652)

  • 1. Clinical application of gene transfer.
    Herrmann F
    J Mol Med (Berl); 1996 Apr; 74(4):213-21. PubMed ID: 8740652
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH Recombinant DNA Advisory Committee data management report. March 12, 1999.
    Hum Gene Ther; 1999 Jun; 10(9):1577-89. PubMed ID: 10395382
    [No Abstract]   [Full Text] [Related]  

  • 3. Department of Health and Human Services. National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting. March 6-7, 1997.
    Hum Gene Ther; 1997 Nov; 8(16):1955-2004. PubMed ID: 9382961
    [No Abstract]   [Full Text] [Related]  

  • 4. Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee. Minutes of meeting March 8-10, 2000.
    Mickelson CA
    Hum Gene Ther; 2000 Oct; 11(15):2159-92. PubMed ID: 11044916
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapies for the hemophilias.
    Thompson AR
    Mol Ther; 2000 Jul; 2(1):5-8. PubMed ID: 10899822
    [No Abstract]   [Full Text] [Related]  

  • 6. Plus ça change..
    Friedmann T
    Mol Ther; 2003 Nov; 8(5):701. PubMed ID: 14632022
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials for cancer gene therapy.
    Cusack JC
    Surg Oncol Clin N Am; 2002 Jul; 11(3):717-825. PubMed ID: 12487064
    [No Abstract]   [Full Text] [Related]  

  • 8. NIH review of gene therapy protocols.
    Varmus H
    Science; 1995 Mar; 267(5206):1889. PubMed ID: 7701310
    [No Abstract]   [Full Text] [Related]  

  • 9. Human gene therapy protocols: RAC review.
    McGarrity GJ; Anderson WF
    Science; 1995 Jun; 268(5215):1261. PubMed ID: 7761842
    [No Abstract]   [Full Text] [Related]  

  • 10. The evolution of public review and oversight mechanisms in human gene transfer research: joint roles of the FDA and NIH.
    Friedmann T; Noguchi P; Mickelson C
    Curr Opin Biotechnol; 2001 Jun; 12(3):304-7. PubMed ID: 11404110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in the United States: a five-year status report.
    Ross G; Erickson R; Knorr D; Motulsky AG; Parkman R; Samulski J; Straus SE; Smith BR
    Hum Gene Ther; 1996 Sep; 7(14):1781-90. PubMed ID: 8886849
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant DNA Advisory Committee. Department of Health and Human Services. National Institutes of Health. Minutes of meeting. December 15-16, 1997.
    Hum Gene Ther; 1998 Jul; 9(11):1643-95. PubMed ID: 9694162
    [No Abstract]   [Full Text] [Related]  

  • 13. NIH Recombinant DNA Advisory Committee data management report. June 18-19, 1998.
    Hum Gene Ther; 1998 Sep; 9(14):2143-61. PubMed ID: 9759940
    [No Abstract]   [Full Text] [Related]  

  • 14. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 15. Department of Health and Human Services, Public Health Service, National Institutes of Health. Human Gene Therapy Subcommittee. Minutes of Meeting, June 1, 1990.
    Recomb DNA Tech Bull; 1990 Dec; 13(4):245-72. PubMed ID: 2093948
    [No Abstract]   [Full Text] [Related]  

  • 16. US drive to speed trials for rare disorders.
    Wadman M
    Nature; 1998 Sep; 395(6697):4. PubMed ID: 9738483
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

  • 18. Future oversight of recombinant DNA research: recommendations of an Institute of Medicine committee.
    Gostin LO; Altevogt BM; Pope AM
    JAMA; 2014 Feb; 311(7):671-2. PubMed ID: 24435443
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols.
    Scharschmidt T; Lo B
    Hum Gene Ther; 2006 Apr; 17(4):448-54. PubMed ID: 16610932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new RAC: restructuring of the National Institutes of Health recombinant DNA Advisory Committee.
    Beach JE
    Food Drug Law J; 1999; 54(1):49-53. PubMed ID: 11758560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.